Evidence map›Paper›PMID 37834008›Full record

ArticleInternational journal of molecular sciences2023

Molecular Characterization and Mutational Analysis of Clarithromycin- and Levofloxacin-Resistance Genes in

Ivica Šamanić, Blanka Dadić, Željka Sanader Maršić, Mia Dželalija, Ana Maravić, Hrvoje Kalinić, Pavle Vrebalov Cindro, Željko Šundov, Marija Tonkić, Ante Tonkić and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. The Challenges of Treating aJournal of clinical medicine · 2024
    Review
  6. Frontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ivica ŠamanićDepartment of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.ORCID 0000-0001-8807-8184
Blanka DadićDepartment of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.
Željka Sanader MaršićDepartment of Physics, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.ORCID 0000-0003-3660-145X
Mia DželalijaDepartment of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.ORCID 0000-0002-7284-9519
Ana MaravićDepartment of Biology, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.
Hrvoje KalinićDepartment of Compute Science, Faculty of Science, University of Split, Ruđera Boškovića 33, 21000 Split, Croatia.
Pavle Vrebalov CindroDepartment of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.
Željko ŠundovDepartment of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.
Marija TonkićDepartment of Medical Microbiology and Parasitology, School of Medicine, University of Split, 21000 Split, Croatia.
Ante TonkićDepartment of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.
Jonatan VukovićDepartment of Gastroenterology, University Hospital of Split, 21000 Split, Croatia.
University of Split · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Point mutations in the

Indexed as

Helicobacter InfectionsHelicobacter pyloriAnti-Bacterial AgentsBiopsyClarithromycinCroatiaDrug Resistance, BacterialHumansLevofloxacinMicrobial Sensitivity TestsMolecular Docking SimulationRNA, Ribosomal, 23SAnti-Bacterial AgentsClarithromycinLevofloxacinRNA, Ribosomal, 23S23S rRNAantibiotic resistancegyrAgyrBmolecular dockingpoint mutations

Identifiers

PMID37834008
PMCPMC10572715
OpenAlexW4387059072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.